Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Purchased by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 26.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 274,773 shares of the pharmacy operator’s stock after buying an additional 57,951 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in Walgreens Boots Alliance were worth $2,564,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Golden State Wealth Management LLC purchased a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth approximately $26,000. Riverview Trust Co increased its position in shares of Walgreens Boots Alliance by 123.8% in the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock valued at $27,000 after purchasing an additional 1,590 shares during the last quarter. Colonial Trust Co SC raised its holdings in shares of Walgreens Boots Alliance by 79.5% in the 4th quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator’s stock valued at $27,000 after purchasing an additional 1,297 shares in the last quarter. Venturi Wealth Management LLC purchased a new stake in shares of Walgreens Boots Alliance during the 4th quarter worth $28,000. Finally, Independence Bank of Kentucky acquired a new position in shares of Walgreens Boots Alliance during the fourth quarter worth $39,000. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, Chairman Stefano Pessina acquired 832,258 shares of the company’s stock in a transaction dated Sunday, April 27th. The stock was acquired at an average cost of $11.01 per share, with a total value of $9,163,160.58. Following the purchase, the chairman now directly owns 145,621,079 shares in the company, valued at approximately $1,603,288,079.79. This trade represents a 0.57% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. 17.50% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on WBA shares. Wolfe Research raised Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. Deutsche Bank Aktiengesellschaft lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating and cut their target price for the stock from $11.00 to $9.00 in a research report on Friday, February 28th. StockNews.com initiated coverage on Walgreens Boots Alliance in a report on Wednesday. They issued a “hold” rating for the company. Finally, Truist Financial dropped their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research note on Friday, January 31st. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Walgreens Boots Alliance currently has an average rating of “Hold” and an average price target of $10.59.

Walgreens Boots Alliance Stock Down 0.2%

Shares of Walgreens Boots Alliance stock opened at $11.23 on Wednesday. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $17.81. The company has a market cap of $9.71 billion, a P/E ratio of -1.10, a PEG ratio of 1.31 and a beta of 0.77. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The firm has a fifty day moving average of $11.02 and a two-hundred day moving average of $10.38.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share for the quarter, beating analysts’ consensus estimates of $0.53 by $0.10. The company had revenue of $38.59 billion for the quarter, compared to analyst estimates of $37.90 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm’s revenue for the quarter was up 4.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.20 EPS. On average, analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.